Enanta Pharmaceuticals Inc (ENTA) stock
ENTANasdaqPharmaceutical PreparationsFiscal year ends September 30
Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 12, 2026Score 2/3018% above fair value
$10.99−0.21 (-1.87%)
Close on Nov 13, 2026Market cap $320.09MP/E –Yield –
Enanta Pharmaceuticals statistics
78 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.
Important dates
- Next earnings
- Nov 16, 2026 (estimated, during market hours)
- Last ex-dividend date
- No dividends
- Fundamentals through
- Jun 30, 2026
- Share price as of
- Nov 13, 2026
Valuation ratiosIndustry
- P/TBV Ratio
- 3.17
- 2.22
Enterprise valuationIndustry
- EV / Sales
- 2.00
- 2.57
Share statisticsIndustry
- Shares Change (QoQ)
- 0.20%
- 0.50%
- Float
- 27M
- 49M
- Shares Held by Insiders
- 7.94%
- 11.7%
- Shares Held by Institutions
- 93.6%
- 56.4%
Short sellingIndustry
- Short Interest
- 2M
- –
- Short Interest Change
- -18.0%
- -0.80%
- Short % of Float
- 6.92%
- 9.01%
- Short % of Shares Outstanding
- 6.37%
- 6.30%
- Days to Cover
- 7.63
- 5.15
Stock price statisticsIndustry
- 52-Week High
- $17.15
- –
- 52-Week Low
- $10.05
- –
- 20-Day Moving Average
- $11.21
- –
- 50-Day Moving Average
- $11.95
- –
- 200-Day Moving Average
- $13.10
- –
- Average True Range (14)
- $0.74
- –
- Price Change (1 Week)
- -0.09%
- -1.15%
- Price Change (1 Month)
- -4.18%
- -4.87%
- Price Change (3 Months)
- -14.3%
- -21.0%
- Price Change (6 Months)
- -18.0%
- -20.6%
- Price Change (YTD)
- -30.3%
- -23.6%
- Price Change (1 Year)
- -7.88%
- -22.4%
- Price Change (3 Years)
- 23.9%
- -29.5%
- Price Change (5 Years)
- -88.0%
- -77.9%
- Price Change (10 Years)
- -65.1%
- -65.4%
- Average Volume (10 Days)
- 277,551
- –
- Average Volume (20 Days)
- 264,620
- –
- Average Volume (90 Days)
- 233,492
- –
- Relative Volume
- 0.55
- 0.70
- Relative Strength Index (14)
- 45.6
- 43.4
- Volatility (1 Year)
- 49.4%
- 80.1%
- Beta (5 Years)
- 1.14
- 1.07
MarginsIndustry
- Pretax Margin
- -96.7%
- -11.6%
- EBITDA Margin
- -82.5%
- -27.7%
- FCF Margin
- -56.6%
- -9.56%
Returns on capitalIndustry
- Return on Equity (ROE)
- -70.1%
- -49.9%
- Return on Assets (ROA)
- -21.2%
- -40.6%
- Return on Capital Employed (ROCE)
- -24.2%
- -37.9%
Financial positionIndustry
- Current Ratio
- 3.76
- 3.30
- Quick Ratio
- 3.62
- 2.39
- Interest Coverage
- -4.55
- -6.35
GrowthIndustry
- Revenue Growth (3Y CAGR)
- -8.82%
- 2.25%
- Revenue Growth (5Y CAGR)
- -11.8%
- 6.41%
EfficiencyIndustry
- Asset Turnover
- 0.22
- 0.40
- Revenue Per Employee
- $543.82K
- $429.29K
- Profits Per Employee
- -$526.92K
- -$689.41K
- Employee Count
- 120
- 74
- WACC
- 10.8%
- 10.2%
Income statement (TTM)Industry
- Pretax Income
- -$63.13M
- -$12.95M
Balance sheetIndustry
- Net Cash (Debt)
- $189.51M
- $17.76M
- Net Cash Per Share
- $6.51
- $0.80
- Equity (Book Value)
- $101.07M
- $53.89M
- Book Value Per Share
- $3.47
- $1.50
- Tangible Book Value
- $101.07M
- $27.13M
- Working Capital
- $149.45M
- $79.99M
Cash flow (TTM)Industry
- Capital Expenditures
- -$1.62M
- -$1.00M
- FCF Per Share
- -$1.27
- -$0.42
Dividends and yieldsIndustry
- Earnings Yield
- -19.8%
- -21.8%
- FCF Yield
- -11.5%
- -9.44%
Taxes and interestIndustry
- Interest Expense
- $12.92M
- $2.90M
- Income Tax
- $99.00K
- $73.00K
Scores and fair valueIndustry
- Altman Z-Score
- -0.97
- 0.23
- Piotroski F-Score
- 4
- 4
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.
| Period | ENTA | S&P 500 | Difference | ENTA per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -4.6% | -3.0% | −1.6 pts | ||
| 3 months | -18.2% | -2.8% | −15.4 pts | ||
| Year to date | -30.3% | +11.5% | −41.8 pts | ||
| 1 year | -6.2% | +13.5% | −19.7 pts | ||
| 3 years | +34.4% | +77.7% | −43.3 pts | +10.3% | +21.1% |
| 5 years | -88.0% | +72.6% | −160.6 pts | -34.5% | +11.5% |
| 10 years | -60.9% | +308.2% | −369.1 pts | -9.0% | +15.1% |
Short interest
Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.
2M ENTA shares were sold short on Oct 30, 2026, down 18.0% from the previous report, or 6.92% of the shares available to trade. At recent volumes it would take 7.6 days to buy them back. Over the last 20 sessions, 47.0% of the volume reported to FINRA was short selling.
| Settlement date | Shares short | Change | Avg. daily volume | Days to cover |
|---|---|---|---|---|
| Oct 30, 2026 | 1,856,510 | -18.0% | 243,263 | 7.6 |
| Oct 15, 2026 | 2,265,069 | -11.3% | 264,255 | 8.6 |
| Sep 30, 2026 | 2,552,994 | -1.8% | 277,685 | 9.2 |
| Sep 15, 2026 | 2,600,199 | -0.6% | 242,451 | 10.7 |
| Aug 31, 2026 | 2,616,446 | -2.4% | 257,672 | 10.2 |
| Aug 14, 2026 | 2,679,755 | +3.6% | 181,762 | 14.7 |
| Jul 31, 2026 | 2,587,297 | +6.0% | 146,348 | 17.7 |
| Jul 15, 2026 | 2,441,185 | -5.5% | 191,239 | 12.8 |
| Jun 30, 2026 | 2,583,579 | +6.4% | 319,284 | 8.1 |
| Jun 15, 2026 | 2,427,371 | +6.7% | 189,612 | 12.8 |
| May 29, 2026 | 2,274,248 | +3.2% | 207,421 | 11.0 |
| May 15, 2026 | 2,202,731 | +2.2% | 235,034 | 9.4 |
Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.
See a number that looks wrong?